Compare RGEN & CLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | CLF |
|---|---|---|
| Founded | 1981 | 1847 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.1B |
| IPO Year | N/A | N/A |
| Metric | RGEN | CLF |
|---|---|---|
| Price | $166.48 | $13.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 12 |
| Target Price | ★ $174.90 | $11.14 |
| AVG Volume (30 Days) | 617.0K | ★ 12.9M |
| Earning Date | 02-19-2026 | 10-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $707,890,000.00 | ★ $18,622,000,000.00 |
| Revenue This Year | $17.84 | $0.41 |
| Revenue Next Year | $12.44 | $7.21 |
| P/E Ratio | $6,513.01 | ★ N/A |
| Revenue Growth | ★ 11.74 | N/A |
| 52 Week Low | $102.97 | $5.63 |
| 52 Week High | $182.52 | $16.70 |
| Indicator | RGEN | CLF |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 57.73 |
| Support Level | $161.41 | $13.38 |
| Resistance Level | $167.65 | $14.02 |
| Average True Range (ATR) | 4.54 | 0.49 |
| MACD | 0.16 | 0.03 |
| Stochastic Oscillator | 89.26 | 66.18 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.